DEFINING THE INFANT IMMUNE RESPONSE TO HIV
定义婴儿对艾滋病毒的免疫反应
基本信息
- 批准号:9076992
- 负责人:
- 金额:$ 78.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-01 至 2020-12-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAddressAdultAffinityAmino AcidsAntibodiesAntibody ResponseB-LymphocytesBindingBiochemicalBiological ModelsBirthBlood CellsBreast FeedingCellsClinical TrialsDataDevelopmentEpitopesEvolutionExperimental ModelsFreezingGenesGrowthHIVHIV AntigensHIV InfectionsHIV vaccineHIV-1Immune responseImmunizationImmunoglobulin GImmunoglobulin Somatic HypermutationIndividualInfantInfectionLifeMapsMethodsMonoclonal AntibodiesNaturePathway interactionsPlasmaPolysaccharidesPositioning AttributeProcessPropertyReceptors, Antigen, B-CellResourcesSamplingSpecificityTimeVaccinesVariantWomanbiophysical techniquescohortdesigninnovationinsightneutralizing antibodynovelprogenitorpublic health relevanceresponsevaccine response
项目摘要
DESCRIPTION (provided by applicant): HIV-specific neutralizing antibodies (Nabs) are considered a critical component of a HIV vaccine response. One of the major challenges to developing an effective Nab response through immunization is that we do not know how to elicit such Nabs. The identification of broad and potent Nabs in adults provided great encouragement for the field, as it suggested that broad and potent antibodies can be elicited in response to HIV antigens. However, the Mabs isolated to date are largely derived from individuals with a long-term HIV infection - in some cases greater than a decade - and a disappointing feature of these antibodies is the extent of affinity maturation and variation from germline, which is greater than 40% in some cases. Thus, while these Mabs helped define epitopes targeted by some notably broad HIV-specific Nabs, they raise challenging issues regarding how to elicit Nabs with these properties, as these responses have evolved after continued HIV sequence variation and stimulation over many years. We believe that because immunization may not be able to mimic this type of long-term affinity maturation process, it is critical to determine if it is possible t elicit a rapid, broad Nab response in HIV infection, and if so, to define how this occurs. We recently discovered that HIV-infected infants develop broad and potent HIV-specific Nab responses, in some cases, within the first year of their infection. Mapping studies suggest that these responses are distinct from those found in most adults with broad Nab activity. We propose here to characterize these novel responses with the following specific AIMs: 1) To isolate HIV-specific monoclonal antibodies from infants with broad Nabs and define whether the breadth of their response is due to a polyclonal response or a monoclonal response. 2) To define the epitope specificity of the Mabs that contributed to the breadth of the infant response. 3) To determine the ontogeny of the antibody gene of the Mab and define the original B cell receptor that recognized HIV to give rise to the later Mab. 4) To define and compare the binding properties of mature versus initial neutralizing antibodies. Infants who developed a rapid robust HIV-specific Nab response may hold important clues to the nature of broad and potent Nabs that can be elicited with shorter-term immunization strategies. We believe that defining the progenitor B cell receptor and the pathway and functional interactions that resulted in such bNabs will provide critical insights into how to elicit such responses with a vaccine.
描述(由申请人提供):艾滋病毒特异性中和抗体(NAB)被认为是艾滋病毒疫苗反应的关键组成部分。通过免疫制定有效的NAB反应的主要挑战之一是,我们不知道如何引发这种NAB。在成人中发现广泛和有效的NAB为该领域提供了极大的鼓舞,因为这表明可以诱导出广泛和有效的抗体来应对艾滋病毒抗原。然而,迄今为止分离的单抗主要来自长期感染艾滋病毒的人--在某些情况下超过十年--这些抗体的一个令人失望的特征是亲和力成熟和与种系的差异程度,在某些情况下超过40%。因此,虽然这些单抗帮助定义了一些特别广泛的HIV特异性NAB所针对的表位,但它们提出了如何利用这些特性诱导NAB的挑战性问题,因为这些反应是在多年的HIV序列持续变异和刺激后演变而来的。我们认为,由于免疫可能无法模拟这种长期的亲和力成熟过程,因此确定是否有可能在HIV感染中引发快速、广泛的NAB反应是至关重要的,如果可能,则定义这种反应是如何发生的。我们最近发现,感染艾滋病毒的婴儿在感染的第一年内,在某些情况下,会产生广泛而有效的艾滋病毒特异性NAB反应。图谱研究表明,这些反应与大多数具有广泛NAB活性的成年人的反应不同。我们建议用以下特定目的来描述这些新的反应:1)从具有广泛NAB的婴儿中分离出HIV特异性的单抗,并确定其反应的广度是由于多克隆反应还是由于单克隆反应。2)确定影响婴儿反应广度的单抗的表位特异性。3)确定单抗抗体基因的个体发育,确定识别HIV的原始B细胞受体,从而产生新的单抗。4)定义和比较成熟中和抗体与初始中和抗体的结合特性。发展出快速、强大的HIV特异性NAB反应的婴儿可能掌握着广泛和有效的NAB的性质的重要线索,这些NAB可以通过短期免疫策略来引发。我们相信,定义祖细胞B细胞受体以及导致这种bNAb的途径和功能相互作用将为如何用疫苗引发这种反应提供关键的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULIE M. OVERBAUGH其他文献
JULIE M. OVERBAUGH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULIE M. OVERBAUGH', 18)}}的其他基金
Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathways
SARS-CoV-2 抗体反应和逃逸途径的综合分析
- 批准号:
10398436 - 财政年份:2020
- 资助金额:
$ 78.73万 - 项目类别:
Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathways
SARS-CoV-2 抗体反应和逃逸途径的综合分析
- 批准号:
10265760 - 财政年份:2020
- 资助金额:
$ 78.73万 - 项目类别:
Characterizing the broad antibody response to HIV superinfection
表征对 HIV 重复感染的广泛抗体反应
- 批准号:
10327673 - 财政年份:2018
- 资助金额:
$ 78.73万 - 项目类别:
Characterizing the broad antibody response to HIV superinfection
表征对 HIV 重复感染的广泛抗体反应
- 批准号:
10088378 - 财政年份:2018
- 资助金额:
$ 78.73万 - 项目类别:
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
建立更相关的 HIV 感染模型
- 批准号:
9144750 - 财政年份:2015
- 资助金额:
$ 78.73万 - 项目类别:
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
建立更相关的 HIV 感染模型
- 批准号:
9526462 - 财政年份:2015
- 资助金额:
$ 78.73万 - 项目类别:
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN
慢性感染女性 HIV-1 抗体反应的特征
- 批准号:
8410017 - 财政年份:2012
- 资助金额:
$ 78.73万 - 项目类别:
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN
慢性感染女性 HIV-1 抗体反应的特征
- 批准号:
8705257 - 财政年份:2012
- 资助金额:
$ 78.73万 - 项目类别:
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN
慢性感染女性 HIV-1 抗体反应的特征
- 批准号:
8521078 - 财政年份:2012
- 资助金额:
$ 78.73万 - 项目类别:
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN
慢性感染女性 HIV-1 抗体反应的特征
- 批准号:
8889191 - 财政年份:2012
- 资助金额:
$ 78.73万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 78.73万 - 项目类别:
Research Grant